Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-SEQ OF APOCC and GOCA2 ovarian cancer cell lines

ABSTRACT: The aim of this study was to establish baseline gene expression data for two primary ovarian cancer cell lines.

ORGANISM(S): Homo sapiens

PROVIDER: GSE202628 | GEO | 2022/05/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression profiling of ovarian cancer cell lines

Project description:Paired platinum-sensitive & platinum-resistant cell lines PEO1 and PEO4 (respectively) were derived from the same patient. Cell line cultures were profiled with the HT-HGU133a GeneChip to investigate chemotherapy resistance related expression of genes marked with different histone modifications in a primary ovarian tumour (clinical data for the primary ovarian tumour is available as Series supplementary file).

2012-10-12 | GSE41499 | GEO

H3K27Ac of Ovarian Cancer Cell Lines

Project description:H3K27Ac of Ovarian Cancer Cell Lines

| PRJNA657252 | ENA

Gene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines.

Project description:We treated 8 human ovarian cancer cell lines with cisplatin in treatment/recovery cycles to induce in-vitro resistance to the drug. Microarrays measured gene expression at baseline and after each dose schedule (after recovery).

2011-10-03 | GSE23553 | GEO

Characterization of novel ovarian tumor cell lines that retain the phenotype of primary tumors [MIP]

Project description:The inability to establish stable cell lines from the vast majority of human tumors has limited the use of in vitro models to study human cancer. Currently available tumor cell lines fail to represent the biological diversity of human tumors. We have developed a cell culture medium that enabled us to routinely establish cell lines from diverse subtypes of ovarian tumors. Importantly, the twenty-five ovarian tumor cell lines described here retain the genomic landscape, histopathology, and molecular features of the original tumors. Furthermore, the molecular profile and drug response of these cell lines correlated with distinct groups of primary tumors with different outcomes. Thus, tumor cell lines derived using this methodology represent a significantly improved new platform to study human tumor biology and treatment. DNA was extracted from 25 OCI (human ovarian cancer) cell lines.

2015-06-16 | E-GEOD-40786 | biostudies-arrayexpress

Gene expression associated with acquired paclitaxel resistance in ovarian cancer cell lines

Project description:Conventional frontline treatment for ovarian cancer consists of successive chemotherapy cycles of paclitaxel and platinum. Despite the initial favorable responses for most patients, chemotherapy resistance frequently leads to recurrent or refractory disease. New treatment strategies that circumvent or prevent mechanisms of resistance are needed to improve ovarian cancer therapy. We developed in vitro ovarian cancer cell line models of acquired paclitaxel resistance using 2 immortalized human ovarian cancer cell lines, OVCAR3 and TOV-21G. We also developed in vitro primary ovarian cancer organoid models using tumor tissue from 7 patients with gynecologic malignancies. Gene expression differences in resistant and sensitive lines were analyzed by RNA sequencing to identify potential mechanisms of paclitaxel resistance in primary ovarian cancer.

2021-07-02 | GSE172016 | GEO

Expression profiling of ovarian cancer cell lines

2012-10-12 | E-GEOD-41499 | biostudies-arrayexpress

Characterization of novel ovarian tumor cell lines that retain the phenotype of primary tumors [SNP]

2015-06-16 | GSE40787 | GEO

Characterization of novel ovarian tumor cell lines that retain the phenotype of primary tumors [Illumina]

2015-06-16 | GSE40785 | GEO

Characterization of novel ovarian tumor cell lines that retain the phenotype of primary tumors [MIP]

2015-06-16 | GSE40786 | GEO

Differentially expressed genes and chromosomal alterations in ovarian cancer cell lines sensitive or resistant to a Src-inihibitor, saracatinib

Project description:We sought to detect predictive markers related to a Src kinase inhibitor (saracatinib) sensitivity in ovarian cancer. Cell proliferation assays assigned 18 ovarian cancer cell lines to sensitive or resistant to this drug. Using baseline gene expression data from these 18 cell lines, we sought to identify differentially expressed genes correlated with saracatinib sensitivity. We also used SNP array data from 7 cell lines to detect differentically affected genomic locations.

2017-03-05 | GSE55628 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data